Published in Neonatology on November 10, 2011
Nebulized PPARγ agonists: a novel approach to augment neonatal lung maturation and injury repair in rats. Pediatr Res (2014) 0.89
PPAR-γ agonist rosiglitazone reverses perinatal nicotine exposure-induced asthma in rat offspring. Am J Physiol Lung Cell Mol Physiol (2015) 0.83
Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotype. PPAR Res (2012) 0.82
Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev (2006) 9.72
Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem (2008) 9.56
Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol (2008) 5.56
Rosiglitazone revisited: an updated meta-analysis of risk for myocardial infarction and cardiovascular mortality. Arch Intern Med (2010) 3.79
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J (2010) 2.68
Long-term outcomes after repeat doses of antenatal corticosteroids. N Engl J Med (2007) 2.30
Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma. Curr Opin Genet Dev (1995) 2.16
Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size. FASEB J (2002) 1.73
Epithelial cell PPAR[gamma] contributes to normal lung maturation. FASEB J (2006) 1.61
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol (2009) 1.50
The role of fibroblast transdifferentiation in lung epithelial cell proliferation, differentiation, and repair in vitro. Pediatr Pathol Mol Med (2003) 1.49
Effect of rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 on bleomycin-induced lung injury. Eur Respir J (2005) 1.49
In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis. Am J Physiol (1994) 1.48
Peroxisome proliferator-activated receptor-{gamma} as a regulator of lung inflammation and repair. Proc Am Thorac Soc (2005) 1.42
A prospective, randomized comparison of the metabolic effects of pioglitazone or rosiglitazone in patients with type 2 diabetes who were previously treated with troglitazone. Diabetes Care (2002) 1.42
In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. Am J Physiol Lung Cell Mol Physiol (2007) 1.39
Fetal sex and prenatal betamethasone therapy. J Pediatr (1980) 1.17
Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, reduces pulmonary inflammatory response in a rat model of endotoxemia. Inflamm Res (2005) 1.16
Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res (2009) 1.09
Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung (2008) 1.06
Early exposure of the pregestational intrauterine and postnatal growth-restricted female offspring to a peroxisome proliferator-activated receptor-{gamma} agonist. Am J Physiol Endocrinol Metab (2009) 0.91
Perinatal expression of genes that may participate in lipid metabolism by lipid-laden lung fibroblasts. J Lipid Res (1998) 0.89
Antenatal retinoic acid does not alter alveolization or postnatal lung function in preterm sheep. Eur Respir J (2000) 0.83
NOTCH reprograms mitochondrial metabolism for proinflammatory macrophage activation. J Clin Invest (2015) 2.93
Perinatal nicotine exposure induces asthma in second generation offspring. BMC Med (2012) 1.51
Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol (2009) 1.50
In utero nicotine exposure alters fetal rat lung alveolar type II cell proliferation, differentiation, and metabolism. Am J Physiol Lung Cell Mol Physiol (2007) 1.39
Evidence for the presence of lipofibroblasts in human lung. Exp Lung Res (2006) 1.38
Developmental cell/molecular biologic approach to the etiology and treatment of bronchopulmonary dysplasia. Pediatr Res (2007) 1.36
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, prevents hyperoxia-induced neonatal rat lung injury in vivo. Pediatr Pulmonol (2006) 1.31
Peroxisome proliferator-activated receptor alpha (PPARalpha) influences substrate utilization for hepatic glucose production. J Biol Chem (2002) 1.29
Increased pentose phosphate pathway flux after clinical traumatic brain injury: a [1,2-13C2]glucose labeling study in humans. J Cereb Blood Flow Metab (2007) 1.28
The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung (2009) 1.25
Peroxisomal proliferator-activated receptor alpha deficiency diminishes insulin-responsiveness of gluconeogenic/glycolytic/pentose gene expression and substrate cycle flux. Endocrinology (2003) 1.25
Lipin deficiency impairs diurnal metabolic fuel switching. Diabetes (2006) 1.19
Thirdhand smoke causes DNA damage in human cells. Mutagenesis (2013) 1.14
PPARγ Signaling Mediates the Evolution, Development, Homeostasis, and Repair of the Lung. PPAR Res (2012) 1.14
Mechanism of nicotine-induced pulmonary fibroblast transdifferentiation. Am J Physiol Lung Cell Mol Physiol (2005) 1.12
Arrested pulmonary alveolar cytodifferentiation and defective surfactant synthesis in mice missing the gene for parathyroid hormone-related protein. Dev Dyn (2004) 1.11
Evidence for in vivo nicotine-induced alveolar interstitial fibroblast-to-myofibroblast transdifferentiation. Exp Lung Res (2010) 1.09
Peroxisome proliferator-activated receptor gamma agonists enhance lung maturation in a neonatal rat model. Pediatr Res (2009) 1.09
Mechanism for nicotine-induced up-regulation of Wnt signaling in human alveolar interstitial fibroblasts. Exp Lung Res (2010) 1.08
Up-regulation of fetal rat lung parathyroid hormone-related protein gene regulatory network down-regulates the Sonic Hedgehog/Wnt/betacatenin gene regulatory network. Pediatr Res (2006) 1.07
Determination of a glucose-dependent futile recycling rate constant from an intraperitoneal glucose tolerance test. Anal Biochem (2003) 1.07
Prevention and treatment of bronchopulmonary dysplasia: contemporary status and future outlook. Lung (2008) 1.06
Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes (2005) 1.06
Perinatal nicotine-induced transgenerational asthma. Am J Physiol Lung Cell Mol Physiol (2013) 1.06
Deconvoluting lung evolution using functional/comparative genomics. Am J Respir Cell Mol Biol (2004) 1.04
Compartmentalization of stearoyl-coenzyme A desaturase 1 activity in HepG2 cells. J Lipid Res (2008) 1.04
1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab (2002) 1.04
Decreased hepatic futile cycling compensates for increased glucose disposal in the Pten heterodeficient mouse. Diabetes (2006) 1.01
PPARγ agonist rosiglitazone prevents perinatal nicotine exposure-induced asthma in rat offspring. Am J Physiol Lung Cell Mol Physiol (2011) 1.00
Antenatally administered PPAR-gamma agonist rosiglitazone prevents hyperoxia-induced neonatal rat lung injury. Am J Physiol Lung Cell Mol Physiol (2010) 0.99
Bombesin-like peptide receptor gene expression, regulation, and function in fetal murine lung. Am J Physiol Lung Cell Mol Physiol (2003) 0.99
Mechanism of reduced lung injury by high-frequency nasal ventilation in a preterm lamb model of neonatal chronic lung disease. Pediatr Res (2011) 0.98
Thirdhand smoke: a new dimension to the effects of cigarette smoke on the developing lung. Am J Physiol Lung Cell Mol Physiol (2011) 0.96
Leptin stimulates Xenopus lung development: evolution in a dish. Evol Dev (2009) 0.95
Evolutionary biology redux. Perspect Biol Med (2013) 0.95
Effect of maternal food restriction on fetal rat lung lipid differentiation program. Pediatr Pulmonol (2009) 0.95
Assessment of exhaled breath condensate pH. Am J Respir Crit Care Med (2011) 0.94
Glucose metabolic adaptations in the intrauterine growth-restricted adult female rat offspring. Am J Physiol Endocrinol Metab (2006) 0.94
A paradoxical temporal response of the PTHrP/PPARgamma signaling pathway to lipopolysaccharide in an in vitro model of the developing rat lung. Am J Physiol Lung Cell Mol Physiol (2007) 0.93
Mechanisms of impaired nephrogenesis with fetal growth restriction: altered renal transcription and growth factor expression. Am J Obstet Gynecol (2008) 0.92
Characterization of a novel fibroblast growth factor 10 (Fgf10) knock-in mouse line to target mesenchymal progenitors during embryonic development. PLoS One (2012) 0.92
Effects of maternal food restriction on offspring lung extracellular matrix deposition and long term pulmonary function in an experimental rat model. Pediatr Pulmonol (2011) 0.91
A potential role of the JNK pathway in hyperoxia-induced cell death, myofibroblast transdifferentiation and TGF-β1-mediated injury in the developing murine lung. BMC Cell Biol (2011) 0.91
Oxygen-induced metabolic changes and transdifferentiation in immature fetal rat lung lipofibroblasts. Mol Genet Metab (2002) 0.91
The lung alveolar lipofibroblast: an evolutionary strategy against neonatal hyperoxic lung injury. Antioxid Redox Signal (2014) 0.90
Sex-specific perinatal nicotine-induced asthma in rat offspring. Am J Respir Cell Mol Biol (2012) 0.90
Curcumin augments lung maturation, preventing neonatal lung injury by inhibiting TGF-β signaling. Am J Physiol Lung Cell Mol Physiol (2011) 0.88
Lower parathyroid hormone-related protein content of tracheal aspirates in very low birth weight infants who develop bronchopulmonary dysplasia. Pediatr Res (2006) 0.87
Exploiting the PTHrP signaling pathway to treat chronic lung disease. Drugs Today (Barc) (2007) 0.85
Deconvoluting lung evolution: from phenotypes to gene regulatory networks. Integr Comp Biol (2007) 0.85
Role of adipose differentiation-related protein in lung surfactant production: a reassessment. J Lipid Res (2006) 0.85
Fasting induces ketoacidosis and hypothermia in PDHK2/PDHK4-double-knockout mice. Biochem J (2012) 0.84
Metyrapone blocks maternal food restriction-induced changes in female rat offspring lung development. Reprod Sci (2013) 0.83
Hepatic de novo lipogenesis in stable low-birth-weight infants during exclusive breast milk feedings and during parenteral nutrition. JPEN J Parenter Enteral Nutr (2005) 0.82
Prenatal rosiglitazone administration to neonatal rat pups does not alter the adult metabolic phenotype. PPAR Res (2012) 0.82
Turnover of nonessential fatty acids in cardiolipin from the rat heart. J Lipid Res (2011) 0.82
Glucose intolerance and lipid metabolic adaptations in response to intrauterine and postnatal calorie restriction in male adult rats. Endocrinology (2012) 0.80
Perfluorooctane sulfonate disturbs Nanog expression through miR-490-3p in mouse embryonic stem cells. PLoS One (2013) 0.78
Comment on "Evo-Devo and the lungfish: the last gasp of intelligent design". FASEB J (2007) 0.76
Hyperinsulinism presenting in childhood and treatment by conservative pancreatectomy. Endocr Pract (2012) 0.76
A new compass for activin research--a triumph for systems biology. Endocrinology (2011) 0.75
"Failure to communicate" due to forgetting "marriage vow"? Am J Respir Crit Care Med (2004) 0.75
Forces in emphysema: Newtonian v quantum mechanics. Am J Respir Crit Care Med (2004) 0.75
PPARs: Regulators and Translational Targets in the Lung. PPAR Res (2012) 0.75
Development of nursing care quality improvement system on website in Japan. Stud Health Technol Inform (2006) 0.75
Post-Progression Survival Associated with Overall Survival in Patients with Advanced Non-Small-Cell Lung Cancer Receiving Docetaxel Monotherapy as Second-Line Chemotherapy. Chemotherapy (2017) 0.75
Randomized Trial to Compare Renal Function and Ductal Response between Indomethacin and Ibuprofen Treatment in Extremely Low Birth Weight Infants. Neonatology (2016) 0.75